The objective of this webinar organised by NATA and supported by an unrestricted educational grant from Pharmacosmos is to provide an overview of the available evidence and practical recommendations on the management of perioperative iron deficiency anaemia.
This on-demand version comprises three pre-recorded presentations and a live panel discussion that took place on September 28, 2020.
Welcome and introduction
Jens Meier, Linz, Austria
Preoperative intravenous iron to treat anaemia before major abdominal surgery – the PREVENTT trial
Andrew A. Klein, Cambridge, UK
Management of iron deficiency anaemia in the perioperative period – why and when?
Donat R. Spahn, Zurich, Switzerland
Optimising patient safety – management of infusion reactions to intravenous iron
Wendy Lim, Hamilton, ON, Canada
Interactive panel discussion
Jean-François Hardy – Andrew A. Klein – Wendy Lim – Jens Meier – Donat R. Spahn
Erratum (Prof. Spahn’s presentation): In the PREVENTT trial, patients assigned to the intravenous iron group received a single 1000 mg dose of ferric carboxymaltose, not 20 mg/kg BW.